A Trial Evaluating Stereotactic Radiotherapy Plus Durvalumab Continuation for Patients With NSCLC Metachronous Oligometastatic Disease Under Durvalumab Consolidation Following Chemoradiation
Clinical trial NCT03955198 · COMPLETED
Trial details
- NCT number
- NCT03955198
- Sponsor
- Institut Claudius Regaud
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-27
- Primary completion
- 2024-08-26
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.